Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the …

Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PortoPH) are pulmonary
vascular consequences of advanced liver disease associated with significant mortality …

Recurrence of primary sclerosing cholangitis (PSC) following liver transplantation has been
suggested; however, it has not been fully defined because of numerous complicating factors …

Liver transplantation is the only effective therapeutic option for patients with end‐stage liver
disease due to primary sclerosing cholangitis (PSC). In this study, we analyzed a single …

Cardiac and cerebral vascular diseases are leading causes of morbidity and death in solid
organ transplant recipients. Immunosuppressant drugs are associated with dyslipidemia, …

Interferon lambda 1 (IFN‐λ1) is a type III IFN that produces intracellular responses similar to
those of IFN‐α but in fewer cell types because of differences in the receptor distribution …

The selection of liver transplantation (LT) candidates with hepatocellular carcinoma (HCC)
is currently validated based on Milan criteria. The use of extended criteria has remained a …

The primary uses of molten salt in energy technologies are in power production and energy
storage. Salts remain a single-phase liquid even at very high temperatures and atmospheric …

BACKGROUND: Chronic infection with hepatitis C virus (HCV) is a major cause of cirrhosis,
hepatocellular carcinoma and liver transplantation.OBJECTIVE: To estimate the burden of …

Both acute kidney injury (AKI) and chronic kidney disease (CKD) are highly prevalent in liver
transplantation, affecting 25% to 50% and 30% to 90% of recipients, respectively. The risk …